Ask Sterling

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Companies Sectors Ask Sterling Compare

Favorites

Revenue Breakdown

Chart: Revenue Breakdown for Innovent Biologics. Values in USD billions. In H2 2025: Revenue 0.971, Gross Profit 0.739, Operating Income -0.001.

Revenue Flow

Chart: Revenue Flow for Innovent Biologics. Q4 2025, values in USD. Revenue 50%, Gross Profit 38%, Cost of Revenue 12%, Operating Income 0%, Net Income 0%.

Balance Sheet

Chart: Balance Sheet for Innovent Biologics. Values in currency. In H2 2025: Total Assets 5.119, Total Liabilities 2.357, Total Equity 2.653.

H2 2016-H2 2025(All available data)

Cash Flow

Chart: Cash Flow for Innovent Biologics. Values in currency. In H2 2025: Operating Cash Flow 1.324, Free Cash Flow 1.293, Capital Expenditures 0.031.

H1 2016-H2 2025

Innovent Biologics (1801.HK) - Compare | Sterling